\documentclass[aspectratio=169]{beamer}
%\documentclass[handout]{beamer}

% language settings
%\usepackage{fontspec, polyglossia}
%\setdefaultlanguage{magyar}

% common packages
\usepackage{amsmath, multimedia, hyperref, color, multirow}
%\usepackage{graphicx}
\usepackage{xcolor}
\definecolor{BlueGreen}{cmyk}{0.85,0,0.33,0}
\usepackage{url}

% TikZ
\usepackage{tikz}
%\usetikzlibrary{arrows.meta, decorations.pathmorphing, decorations.pathreplacing, shapes.geometric,mindmap}
%\usetikzlibrary{shapes.geometric,fadings,bayesnet}

% beamer styles
\mode<presentation>{
%\usetheme{Madrid}
\usetheme{default}
%\usetheme{Antibes}
%\usecolortheme{beaver}
\usecolortheme{default}
%\usecolortheme{dove}
%\usefonttheme{structureitalicserif}
\setbeamercovered{transparent}
}
\setbeamertemplate{blocks}[rounded][shadow=true]
\AtBeginSubsection[]{
  \begin{frame}<beamer>{Contents}
    \tableofcontents[currentsection,currentsubsection]
  \end{frame}
}
%\useoutertheme[]{tree}

% title, etc
\title{Bayesian analysis of cell based assays}
\subtitle{}
\author{Attila Jones}
\date{}

\begin{document}

\titlepage

\begin{frame}<1>[label=summary]{\alt<1>{Introduction}{Summary}}
\begin{columns}[t]
\begin{column}{0.5\textwidth}

\begin{tabular}{c|c}
\hline
Old approach & New approach \\
\hline
frequentist & Bayesian \\
2-sample test & regression \\
\hline
\end{tabular}

\vspace{2em}

\begin{itemize}
\item<1-> Expectations (New approach)
\begin{itemize}
  \item more powerful
  \item more robust (batch effects, false discoveries)
  \item easy aggregation over assays
  \item $P(H_1)$: direct interpretation
  \item hard to implement
\end{itemize}
\item<2> Findings (New approach)
\begin{itemize}
  \item some agreements with Old approach
  \item fitted curves validate New approach
\end{itemize}
\end{itemize}
\end{column}

\begin{column}{0.5\textwidth}

\includegraphics<2>[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/H102_posteriors-exper-mean-barchart.pdf}

\vspace{2em}

\begin{itemize}
%\item<2> Chenodiol, Arundine: some strong protective effects
%\begin{itemize}
%  \item A$\beta$ clearance
%  \item A$\beta$ release
%  \item LPS neuroinflammation
%\end{itemize}
%\item<2> however, adverse effects weaken the protective ones
%\begin{itemize}
%  \item A$\beta$ clearance
%  \item A$\beta$ release
%  \item LPS neuroinflammation
%\end{itemize}
\item<2> next up: comprehensive analysis of 25+ compounds
\end{itemize}

\end{column}
\end{columns}
\end{frame}

\begin{frame}{Bayesian regression}{Fold change $\mathrm{FC}_y$, hypotheses,
  prior \& posterior probabilities}
\begin{columns}[t]
\begin{column}{0.5\textwidth}

\includegraphics[scale=0.5]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/prior-posterior-curves-sigmoid-2.pdf}
\end{column}
\begin{column}{0.5\textwidth}

%\includegraphics<1>[scale=0.5]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/prior-posterior-density-complex-sigmoid-2.pdf}
\includegraphics[scale=0.5]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/prior-posterior-density-violin-vertical.pdf}
\end{column}
\end{columns}
\end{frame}

\begin{frame}{Posterior probability densities of fold change $\mathrm{FC}_y$}
\begin{center}
\includegraphics[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/violin-posterior-pdf-legend.pdf}
\end{center}
\end{frame}

\begin{frame}{Posterior probability of a protective, a neutral, and an adverse effect}% $\{H_i\}$}
\begin{columns}[t]
\begin{column}{0.5\textwidth}

\includegraphics[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/H102_posteriors-barchart-e2l_textbox.pdf}
\end{column}

\begin{column}{0.5\textwidth}

\end{column}
\end{columns}
\end{frame}

\begin{frame}{Aggregating results accross assays and experiments}
\begin{columns}[t]
\begin{column}{0.5\textwidth}

\includegraphics[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/H102_posteriors-barchart.pdf}
\end{column}

\begin{column}{0.5\textwidth}

\includegraphics[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/H102_posteriors-exper-mean-barchart.pdf}
\end{column}
\end{columns}
\end{frame}

\begin{frame}{Bayesian vs.~Frequentist test of drug effect}
\begin{center}
\includegraphics<1>[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/dunnett-bayes-scatter.pdf}
\includegraphics<2>[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/dunnett-bayes-scatter-numbered-color.pdf}
\end{center}
\end{frame}

\begin{frame}{Bayesian vs.~Frequentist test of $H_1$: protective effect}
\begin{columns}[c]
\begin{column}{0.5\textwidth}

\includegraphics[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/dunnett-bayes-scatter-numbered-color-H1.pdf}
\end{column}
\begin{column}{0.5\textwidth}

\includegraphics<1>[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/dunnett-bayes-curves-H1-Dunnett-true.png}
\includegraphics<2>[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/dunnett-bayes-curves-H1-Bayes-true.png}
\end{column}
\end{columns}
\end{frame}

\begin{frame}{Bayesian vs.~Frequentist test of $H_2$: adverse effect}
\begin{columns}[c]
\begin{column}{0.5\textwidth}

\includegraphics[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/dunnett-bayes-scatter-numbered-color-H2.pdf}
\end{column}
\begin{column}{0.5\textwidth}

\includegraphics<1>[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/dunnett-bayes-curves-H2-Dunnett-true.png}
\includegraphics<2>[scale=0.4]{../../../notebooks/2023-09-26-cell-bayes-assays/named-figure/dunnett-bayes-curves-H2-Bayes-true.png}
\end{column}
\end{columns}
\end{frame}

\againframe{summary}


\end{document}

\begin{columns}[t]
\begin{column}{0.5\textwidth}
\end{column}

\begin{column}{0.5\textwidth}

\end{column}
\end{columns}
